# Public Interest in the Off-Label Use of Glucagon-like Peptide 1 Agonists (Ozempic) for Cosmetic Weight Loss: A Google Trends Analysis

Article · Sabrina H. Han, Rachel H. Safeek, Kyle M. Ockerman, Nhan Trieu, Patricia Mars, Audrey Klenke, Heather J. Furnas, Sarah C. Sorice-Virk

- Archive id: doi:10.1093/asj/sjad211
- Published: 2023-07-02
- Venue: Aesthetic Surgery Journal
- DOI: https://doi.org/10.1093/asj/sjad211
- PMID: 37402640
- Citations: 209
- Source URL: https://doi.org/10.1093/asj/sjad211
- PDF: https://academic.oup.com/asj/advance-article-pdf/doi/10.1093/asj/sjad211/51004228/sjad211.pdf
- Provenance: openalex

_Abstract not reproduced: its license does not permit redistribution. See the source URL._

Topics: [GLP-1 & Incretin Therapies](https://space-kitty.com/topics/glp1-metabolic)

---
Space Kitty Archive · https://space-kitty.com · API: https://space-kitty.com/api/v1 · MCP: https://space-kitty.com/mcp · Premium: $0.20/request via x402 (Base Sepolia (testnet)). Metadata: arXiv (CC0), OpenAlex (CC0), Europe PMC (CC BY/CC0 works), ClinicalTrials.gov.